Kasabach-Merritt phenomenon (KMP) is a rare consumptive coagulopathy associated with specific vascular tumors, kaposiform hemangioendothelioma, and tufted angioma. Kasabach-Merritt phenomenon, characterized by profound thrombocytopenia, hypofibrinogenemia, elevated fibrin split products, and rapid tumor growth, can be life-threatening. Severe symptomatic anemia may also be present. With prompt diagnosis and management, KMP can resolve and vascular tumors have been shown to regress. This review highlights the clinical presentation, histopathology, management, and treatment of KMP associated with kaposiform hemangioendothelioma, and less frequently tufted angioma. A classic clinical case is described to illustrate the presentation and our management of a patient with KMP.
CITATION STYLE
Mahajan, P., Margolin, J., & Iacobas, I. (2017, March 15). Kasabach-Merritt Phenomenon: Classic Presentation and Management Options. Clinical Medicine Insights: Blood Disorders. SAGE Publications Ltd. https://doi.org/10.1177/1179545X17699849
Mendeley helps you to discover research relevant for your work.